"There is no evidence that insulin, however formulated, causes cancer," said Ulf Smith, MD, president of the European Association for the Study of Diabetes (EASD), and Edwin Gale, MD, editor of Diabetologia.
"There is no evidence of an overall increase in the rate of cancer development in patients on insulin glargine, and some suggestion that the risk may actually be reduced. There is no evidence of harm in type 1 diabetes or in premenopausal breast cancer."
Read this full articlehere.One then wonders why Diabetologia initially published the claim that LANTUS might increase cancer risk in the first place. One also wonders why there was the early warning of the potential announcement on June 11th. One then wonders how many individuals, in how many ways, might profit from this series of events at how many others' expense.
|
Read this full articlehere.
One then wonders why Diabetologia initially published the claim that LANTUS might increase cancer risk in the first place. One also wonders why there was the early warning of the potential announcement on June 11th. One then wonders how many individuals, in how many ways, might profit from this series of events at how many others' expense.